Cognitive decline and dementia in diabetes - Systematic overview of prospective observational studies

Diabetologia

Volumn 48, Issue 12, 2005, Pages 2460-2469

  Cukierman, T ^a,c   Gerstein, H C ^a   Williamson, J D ^b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c Department of Medicine ^*  (Canada)

Author keywords

Cognition; Cognitive decline; Dementia; Diabetes; Meta analysis; Prospective studies; Systematic review

Indexed keywords

CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; DEMENTIA; DIABETIC NEUROPATHY; FOLLOW UP; HUMAN; INFORMATION RETRIEVAL; MEDICAL ASSESSMENT; MEDICAL LITERATURE; META ANALYSIS; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SYSTEMATIC REVIEW;

COGNITION; COGNITION DISORDERS; DEMENTIA; DIABETES COMPLICATIONS; DIABETES MELLITUS; FOLLOW-UP STUDIES; HUMANS; INTELLIGENCE TESTS; LONGITUDINAL STUDIES; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 28444491100     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-0023-4     Document Type: Review

References (82)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053
2. Thomas VS, Darvesh S, MacKnight C, Rockwood K (2001) Estimating the prevalence of dementia in elderly people: a comparison of the Canadian Study of Health and Aging and National Population Health Survey approaches. Int Psychogeriatr 13 (Suppl 1):169-175
3. Allen KV, Frier BM, Strachan MW (2004) The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490:169-175
4. Areosa Sastre A, Grimley Evans J (2005) Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane Library, Issue 2,http://www.cochrane.org/cochrane/revabstr/ AB003804.htm
5. Lobo A, Launer LJ, Fratiglioni L et al (2000) Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 54(Suppl 5):S4-S9
6. Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16:93-112
7. Awad N, Gagnon M, Messier C (2004) The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 26:1044-1080
8. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH (2002) Ageing and diabetes: implications for brain function. Eur J Pharmacol 441:1-14
9. Strachan MW, Frier BM, Deary IJ (2003) Type 2 diabetes and cognitive impairment. Diabet Med 20:1-2
10. Strachan MW, Deary IJ, Ewing FM, Frier BM (1997) Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20:438-445
11. Strachan MW, Frier BM, Deary IJ (1997) Cognitive assessment in diabetes: the need for consensus. Diabet Med 14:421-422
12. Horwitz RI, Feinstein AR (1979) Methodologic standards and contradictory results in case-control research. Am J Med 66:556-564
13. Morris MC, Evans DA, Hebert LE, Bienias JL (1999) Methodological issues in the study of cognitive decline. Am J Epidemiol 149:789-793
14. Colsher PL, Wallace RB (1991) Epidemiologic considerations in studies of cognitive function in the elderly: methodology and nondementing acquired dysfunction. Epidemiol Rev 13:1-27
15. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
16. Teng EL, Chui HC (1987) The Modified Mini-Mental State (3MS) examination. J Clin Psychiatr 48:314-318
17. Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922-935
18. Brayne C, Spiegelhalter DJ, Dufouil C et al (1999) Estimating the true extent of cognitive decline in the old. J Am Geriatr Soc 47:1283-1288
19. Wechsler D (1981) The Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation, New York
20. Laird NM, Mosteller F (1990) Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6:5-30
21. Desmond DW, Moroney JT, Sano M, Stern Y (1996) Recovery of cognitive function after stroke. Stroke 27:1798-1803
22. Dik MG, Deeg DJ, Bouter LM, Corder EH, Kok A, Jonker C (2000) Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: a population-based study. Stroke 31:2431-2436
23. Henon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D (2001) Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 57:1216-1222
24. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D (1996) Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 27:2230-2235
25. Hewer W, Mussell M, Rist F, Kulzer B, Bergis K (2003) Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes. Gerontology 49:86-92
26. Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H (1993) The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 48:M117-M121
27. Korten AE, Henderson AS, Christensen H et al (1997) A prospective study of cognitive function in the elderly. Psychol Med 27:919-930
28. de Moraes SA, Szklo M, Tilling K, Sato R, Knopman D (2003) Cognitive functioning as a predictor of ischemic stroke incidence. Epidemiology 14:673-679
29. Feskens EJ, Havekes LM, Kalmijn S, de KP, Launer LJ, Kromhout D (1994) Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ 309:1202-1206
30. Gregg EW, Mangione CM, Cauley JA et al (2002) Diabetes and incidence of functional disability in older women. Diabetes Care 25:61-67
31. Grodstein F, Chen J, Pollen DA et al (2000) Postmenopausal hormone therapy and cognitive function in healthy older women. J Am Geriatr Soc 48:746-752
32. Hu FB, Stampfer MJ, Solomon CG et al (2001) The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161:1717-1723
33. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM (1999) Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 150:283-289
34. Launer LJ, Feskens EJ, Kalmijn S, Kromhout D (1996) Smoking, drinking, and thinking. The Zutphen Elderly Study. Am J Epidemiol 143:219-227
35. Launer LJ, Ross GW, Petrovitch H et al (2000) Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 21:49-55
36. Lui LY, Stone K, Cauley JA, Hillier T, Yaffe K (2003) Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc 51:38-43
37. Ott A, Stolk RP, Hofman A, van HF, Grobbee DE, Breteler MM (1996) Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39:1392-1397
38. Szklo M, Cerhan J, Diez-Roux AV et al (1996) Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 144:1048-1057
39. Wilson RS, Beckett LA, Bienias JL, Evans DA, Bennett DA (2003) Terminal decline in cognitive function. Neurology 60:1782-1787
40. Yaffe K, Cauley J, Sands L, Browner W (1997) Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol 54:1110-1114
41. Yaffe K, Grady D, Pressman A, Cummings S (1998) Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women. J Am Geriatr Soc 46:816-821
42. Yaffe K, Browner W, Cauley J, Launer L, Harris T (1999) Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc 47:1176-1182
43. Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K (2001) A prospective study of physical activity and cognitive decline in elderly women: women who walle. Arch Intern Med161:1703-1708
44. de Moraes SA, Szklo M, Knopman D, Park E (2001) Prospective assessment of estrogen replacement therapy and cognitive functioning: atherosclerosis risk in communities study. Am J Epidemiol 154:733-739
45. Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A (1999) Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology 53:1948-1952
46. Logroscino G, Kang JH, Grodstein F (2004) Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ 328:548
47. Nguyen HT, Black SA, Ray LA, Espino DV, Markides KS (2002) Predictors of decline in MMSE scores among older Mexican Americans. J Gerontol A Biol Sci Med Sci 57:M181-M185
48. Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of diabetes on cognitive function among older Latinos: a population-based cohort study. J Clin Epidemiol 56:686-693
49. Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH (2003) Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13:369-376
50. Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ (2003) Prevalence of dementia in older Ltinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc 51:169-177
51. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366-370
52. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L (1999) The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282:40-46
53. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO (1993) Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 3:358-366
54. Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174-180
55. Tilvis RS, Kahonen-Vare MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE (2004) Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 59:268-274
56. Ott A, Stolk RP, van HF, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53:1937-1942
57. Yoshitake T, Kiyohara Y, Kato I et al (1995) Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45:1161-1168
58. Leibson CL, Rocca WA, Hanson VA et al (1997) Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145:301-308
59. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R (2001) Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multi-ethnic cohort. Am J Epidemiol 154:635-641
60. Cerhan JR, Folsom AR, Mortimer JA et al (1998) Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 44:95-105
61. Knopman D, Boland LL, Mosley T et al (2001) Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56:42-48
62. Stewart R, Prince M, Mann A (2003) Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population. J Am Geriatr Soc 51:1547-1553
63. Robertson-Tchabo EA, Arenberg D, Tobin JD, Plotz JB (1986) A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men. Exp Gerontol 21:459-467
64. MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14:77-83
65. Hassing LB, Hofer SM, Nilsson SE et al (2004) Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33:355-361
66. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661-666
67. Peila R, Rodriguez BL, Launer LJ, Honolulu-Asia AS (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51:1256-1262
68. Tervo S, Kivipelto M, Hanninen T et al (2004) Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 17:196-203
69. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327-1333
70. Yaffe K, Blackwell T, Kanaya AM, Davidowitz BA, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658-663
71. Elias PK, Elias MF, D'Agostino RB et al (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 20:1388-1395
72. Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G (2003) Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc 51:410-414
73. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069-1078
74. Swainson R, Hodges JR, Galton CJ et al (2001) Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord 12:265-280
75. Comijs HC, van TT, Geerlings SW et al (2004) Do severity and duration of depressive symptoms predict cognitive decline in older persons? Results of the Longitudinal Aging Study Amsterdam. Aging Clin Exp Res 16:226-232
76. Paterniti S, Verdier-Taillefer MH, Dufouil C, Alperovitch A (2002) Depressive symptoms and cognitive decline in elderly people. Longitudinal study. Br J Psychiatr 181:406-410
77. Jorm AF (2000) Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 46:219-227
78. Reichard P, Pihl M (1994) Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm diabetes intervention study. Diabetes 43:313-317
79. Horie K, Miyata T, Yasuda T et al (1997) Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem Biophys Res Commun 236:327-332
80. Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151
81. Messier C (2004) Glucose improvement of memory: a review. Eur J Pharmacol 490:33-57
82. Nasreddine ZS, Phillips NA, Bedirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695-699